SGB-ALK7

N/A

Report date: 2026/04/03 20:03:44
NME

Base Information

Drug NameSGB-ALK7
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionActivin receptor type-1C inhibitors
TargetsActivin receptor type-1C
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSanegeneBio Inc
China Registration ClassN/A

Develop Information

Active CompaniesSanegeneBio Inc
Inactive CompaniesN/A
Active IndicationsObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A